Literature DB >> 15173702

Pathophysiology of severe pulmonary hypertension in the critically ill patient.

G Via1, A Braschi.   

Abstract

Pulmonary hypertension (PH) is a threatening condition that can be associated with a great variety of both pulmonary and extrapulmonary diseases. In all forms of severe PH the pulmonary vascular bed looses its physiological features of a "high flow-low pressure system", putting an increased afterload on the right ventricle (RV). Acute pulmonary hypertension in the intensive care unit often represents a clinical problem secondary to acute respiratory failure, left heart failure, pulmonary embolism, or decompensation of prior PH by concurrent pulmonary or cardiovascular disease. Right ventricular failure (acute cor pulmonale) occurs when relevant increases in pulmonary vascular resistance overwhelm its compensatory mechanisms, both abruptly on a previously normal RV, or gradually on a chronic cor pulmonale. This review addresses the main pathophysiological aspects of severe PH, focusing on the hemodynamic derangements occurring in the setting of acute cor pulmonale, and emphasizing the role of ventricular interdependence (the way right ventricular failure greatly affects diastolic and systolic function of the left ventricle), the risk of RV ischemia (the end stage of RV failure) and systemic organ hypoperfusion (caused by antegrade and retrograde heart failure). The understanding of the peculiar features of this type of cardiovascular insufficiency is necessary to both provide effective monitoring and adequate supportive therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15173702

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  9 in total

1.  Increase in exhaled nitric oxide and protective role of the nitric oxide system in experimental pulmonary embolism.

Authors:  K F Nilsson; L E Gustafsson; L C Adding; D Linnarsson; P Agvald
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

Review 2.  Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies.

Authors:  Mobusher Mahmud; Hunter C Champion
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

3.  Bronchoscopy versus an endotracheal tube mounted camera for the peri-interventional visualization of percutaneous dilatational tracheostomy - a prospective, randomized trial (VivaPDT).

Authors:  Jörn Grensemann; Lars Eichler; Sophie Kähler; Dominik Jarczak; Marcel Simon; Hans O Pinnschmidt; Stefan Kluge
Journal:  Crit Care       Date:  2017-12-29       Impact factor: 9.097

4.  Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.

Authors:  Kristofer F Nilsson; Lars E Gustafsson
Journal:  Pharmacol Res Perspect       Date:  2019-01-22

5.  A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension.

Authors:  Anna Stene Hurtsén; Ilya Zorikhin Nilsson; Emanuel M Dogan; Kristofer F Nilsson
Journal:  Drug Des Devel Ther       Date:  2020-02-17       Impact factor: 4.162

Review 6.  Arterial pulmonary hypertension in noncardiac intensive care unit.

Authors:  Mykola V Tsapenko; Arseniy V Tsapenko; Thomas Bo Comfere; Girish K Mour; Sunil V Mankad; Ognjen Gajic
Journal:  Vasc Health Risk Manag       Date:  2008

7.  Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Intensive care management of pulmonary hypertension.

Authors:  M Ali Al-Azem; Manal S Al-Hazmi
Journal:  Ann Thorac Med       Date:  2014-07       Impact factor: 2.219

8.  Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs.

Authors:  Kristofer F Nilsson; Waldemar Goździk; Claes Frostell; Stanisław Zieliński; Marzena Zielińska; Kornel Ratajczak; Piotr Skrzypczak; Sylwia Rodziewicz; Johanna Albert; Lars E Gustafsson
Journal:  Drug Des Devel Ther       Date:  2018-03-29       Impact factor: 4.162

Review 9.  Pulmonary Hypertension in Intensive Care Units: An Updated Review.

Authors:  Armin Nowroozpoor; Majid Malekmohammad; Seyyed Reza Seyyedi; Seyed Mohammadreza Hashemian
Journal:  Tanaffos       Date:  2019-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.